Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 20 for:    Oxacillin

A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02208063
Recruitment Status : Terminated (Halted due to lack of statistical power. No safety concerns identified. Enrolled subjects were allowed to complete scheduled study activities.)
First Posted : August 4, 2014
Last Update Posted : January 15, 2019
Sponsor:
Information provided by (Responsible Party):
Cumberland Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 12, 2018
Actual Study Completion Date : April 12, 2018